Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Recurrent C. Difficile Infection
NCT02557685Phase 2Unknown
- Sponsor
- The Miriam Hospital
- Start
- Jun 2015
- Primary completion
- Mar 2016
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic fecal microbiota in Clostridium difficile infection (CDI), sponsored by The Miriam Hospital. Status: unknown.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT02557685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02557685.